Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Unknown 1Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Vitamin D Deficiency 3Precursor Cell Lymphoblastic Leukemia-Lymphoma 3Polycystic Ovary Syndrome 2Neoplasms 1Multiple Sclerosis, Relapsing-Remitting 1Giant Cell Tumor of Bone 1Gastrointestinal Neoplasms 1Cognitive Dysfunction 1Cholangiocarcinoma 1Carcinoma, Ovarian Epithelial 1Carcinoma, Hepatocellular 1Cachexia 1

Interventions

Drug Therapy 4apatinib 3Oxaliplatin 3pemigatinib 2pembrolizumab 2cemiplimab 2avelumab 2atezolizumab 2S 1 (combination) 2Nivolumab 2Leucovorin 2Irinotecan 2Folfox protocol 2Fluorouracil 2Everolimus 2Erlotinib Hydrochloride 2Endoscopic Mucosal Resection 2Docetaxel 2Capecitabine 2CGX1321 2vandetanib 1titanium silicide 1tepotinib 1tegafur-gimeracil-oteracil 1talazoparib 1sodium thiosulfate 1selpercatinib 1rucaparib 1pralsetinib 1ponatinib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Unknown × Gastrointestinal Neoplasms × Vitamin D × Clear all
NCT05552729 2022-09-23

Effects of Different Doses of Vitamin D on Cancer-related Cognitive Impairment in Patients With Gastrointestinal Tumors

Yangzhou University

Phase 1/2 Unknown
114 enrolled
Gastrointestinal

Gastrointestinal Neoplasms, Cognitive Dysfunction

Data powered by HemOnc (CC BY 4.0) Colophon âš¡